Personalized medicine and disruptive innovation: implications for technology assessment
Genet Med
.
2009 Aug;11(8):577-81.
doi: 10.1097/GIM.0b013e3181ae0935.
Authors
Kevin A Schulman
1
,
Ana Valverde Vidal
,
D Clay Ackerly
Affiliation
1
Duke Clinical Research Institute, Duke Translational Medicine Institute, Durham, North Carolina, USA. kevin.schulman@duke.edu
PMID:
19606052
DOI:
10.1097/GIM.0b013e3181ae0935
No abstract available
MeSH terms
Delivery of Health Care / methods
Delivery of Health Care / trends
Diffusion of Innovation*
Humans
Information Dissemination / methods*
Personal Health Services / methods*
Technology Assessment, Biomedical / methods